ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged drug tested to shrink tumors before esophageal cancer surgery
Disease control Not yet recruitingThis study is testing a new drug called Ivonescimab, given with standard chemotherapy, to patients with a type of esophageal cancer before they have surgery. The goal is to see if this combination can shrink the tumor more effectively and reduce the chance of the cancer coming ba…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 00:42 UTC
-
Cancer clock: does treatment timing matter?
Disease control Not yet recruitingThis study is testing whether the time of day a patient receives immunotherapy affects how well it works for esophageal cancer. It will involve 90 patients with a specific type of esophageal cancer that can be surgically removed. Patients will receive a combination of immunothera…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for Tough-to-Treat esophageal cancer: major trial tests promising drug combo
Disease control Not yet recruitingThis study is testing whether a new combination of two investigational drugs (SYS6010 and SG001), with or without standard chemotherapy, works better than current standard treatments for people with advanced esophageal cancer that has spread. It will involve about 737 adults who …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
New cancer injection tested in patients out of options
Disease control Not yet recruitingThis is the first human study of an experimental injection called IPM514 for people with advanced esophageal cancer that has spread or returned after standard treatments. The main goal is to find a safe dose by testing six different strength levels in 36 patients. Researchers wil…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Beijing Immupeutics Medicine Technology Limited • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC
-
Scientists map hidden battle inside tumors to crack cancer treatment code
Knowledge-focused Not yet recruitingThis study aims to learn why some patients with esophageal cancer respond well to a combination of chemotherapy and immunotherapy before surgery, while others do not. Researchers will analyze small tissue samples taken before and after treatment from about 12 patients using advan…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Nanjing Medical University • Aim: Knowledge-focused
Last updated Apr 02, 2026 00:41 UTC